🇺🇸 FDA
Patent

US 7973163

Fused quinoline derivative and use thereof

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7973163 (Fused quinoline derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/08, A61P1/12